Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2010 1
2011 1
2012 1
2014 2
2015 3
2016 6
2017 8
2018 7
2019 7
2020 8
2021 9
2022 13
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A, Kahya U, Linge A, Chen O, Löck S, Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, Skvortsov S, Negro G, Aschenbrenner B, Skvortsova II, Mirtschink P, Lohaus F, Hölscher T, Neubauer H, Rivandi M, Labitzky V, Lange T, Franken A, Behrens B, Stoecklein NH, Toma M, Sommer U, Zschaeck S, Rehm M, Eisenhofer G, Schwager C, Abdollahi A, Groeben C, Kunz-Schughart LA, Baretton GB, Baumann M, Krause M, Peitzsch C, Dubrovska A. Mukha A, et al. Among authors: linge a. Theranostics. 2021 Jun 26;11(16):7844-7868. doi: 10.7150/thno.58655. eCollection 2021. Theranostics. 2021. PMID: 34335968 Free PMC article.
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I, Offermann A, Püschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, Freytag V, Haider MT, Fjeldbo CS, Di Gaetano S, Schwarz FM, Patil S, Borkowetz A, Erb HHH, Baniahmad A, Mircetic J, Lyng H, Löck S, Linge A, Lange T, Knopf F, Wielockx B, Krause M, Perner S, Dubrovska A. Gorodetska I, et al. Among authors: linge a. Theranostics. 2024 Jan 1;14(2):714-737. doi: 10.7150/thno.88057. eCollection 2024. Theranostics. 2024. PMID: 38169509 Free PMC article.
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.
Tawk B, Rein K, Schwager C, Knoll M, Wirkner U, Hörner-Rieber J, Liermann J, Kurth I, Balermpas P, Rödel C, Linge A, Löck S, Lohaus F, Tinhofer I, Krause M, Stuschke M, Grosu AL, Zips D, Combs SE, Belka C, Stenzinger A, Herold-Mende C, Baumann M, Schirmacher P, Debus J, Abdollahi A. Tawk B, et al. Among authors: linge a. Clin Cancer Res. 2023 Aug 15;29(16):3051-3064. doi: 10.1158/1078-0432.CCR-22-3790. Clin Cancer Res. 2023. PMID: 37058257 Free PMC article.
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, Kücken M, Perner S, Hölscher T, Dubrovska A, Krause M, Kurth I, Baumann M, Peitzsch C. Klusa D, et al. Among authors: linge a. Int J Cancer. 2023 Jun 15;152(12):2639-2654. doi: 10.1002/ijc.34457. Epub 2023 Mar 13. Int J Cancer. 2023. PMID: 36733230
Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy.
Linge A, Schmidt S, Lohaus F, Krenn C, Bandurska-Luque A, Platzek I, von Neubeck C, Appold S, Nowak A, Gudziol V, Buchholz F, Baretton GB, Baumann M, Löck S, Krause M. Linge A, et al. Clin Transl Radiat Oncol. 2019 Mar 18;16:40-47. doi: 10.1016/j.ctro.2019.03.002. eCollection 2019 May. Clin Transl Radiat Oncol. 2019. PMID: 30993218 Free PMC article.
62 results